Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Folate-PEG-NOTA-Al18F: A New Folate Based Radiotracer for PET Imaging of Folate Receptor-Positive Tumors.

Chen Q, Meng X, McQuade P, Rubins D, Lin SA, Zeng Z, Haley H, Miller P, González Trotter D, Low PS.

Mol Pharm. 2017 Dec 4;14(12):4353-4361. doi: 10.1021/acs.molpharmaceut.7b00415. Epub 2017 Nov 1.

PMID:
29028357
2.

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy.

Myers RW, Guan HP, Ehrhart J, Petrov A, Prahalada S, Tozzo E, Yang X, Kurtz MM, Trujillo M, Gonzalez Trotter D, Feng D, Xu S, Eiermann G, Holahan MA, Rubins D, Conarello S, Niu X, Souza SC, Miller C, Liu J, Lu K, Feng W, Li Y, Painter RE, Milligan JA, He H, Liu F, Ogawa A, Wisniewski D, Rohm RJ, Wang L, Bunzel M, Qian Y, Zhu W, Wang H, Bennet B, LaFranco Scheuch L, Fernandez GE, Li C, Klimas M, Zhou G, van Heek M, Biftu T, Weber A, Kelley DE, Thornberry N, Erion MD, Kemp DM, Sebhat IK.

Science. 2017 Aug 4;357(6350):507-511. doi: 10.1126/science.aah5582. Epub 2017 Jul 13.

PMID:
28705990
3.

In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET.

González Trotter DE, Meng X, McQuade P, Rubins D, Klimas M, Zeng Z, Connolly BM, Miller PJ, O'Malley SS, Lin SA, Getty KL, Fayadat-Dilman L, Liang L, Wahlberg E, Widmark O, Ekblad C, Frejd FY, Hostetler ED, Evelhoch JL.

J Nucl Med. 2017 Nov;58(11):1852-1857. doi: 10.2967/jnumed.117.191718. Epub 2017 Jun 6.

4.

In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs.

Campbell BR, Gonzalez Trotter D, Hines CD, Li W, Patel M, Zhang W, Evelhoch JL.

ILAR J. 2016 Dec;57(2):212-220. doi: 10.1093/ilar/ilw019.

5.

Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.

Chen Q, Meng X, McQuade P, Rubins D, Lin SA, Zeng Z, Haley H, Miller P, González Trotter D, Low PS.

Mol Pharm. 2016 May 2;13(5):1520-7. doi: 10.1021/acs.molpharmaceut.5b00989. Epub 2016 Apr 18.

6.

Comparison of the in vivo distribution of four different annexin a5 adducts in rhesus monkeys.

McQuade P, Belanger MJ, Meng X, Guenther I, Krause S, Gonzalez Trotter D, Reutelingsperger C, Hostetler E, Klimas M, Mehmet H, Cook J.

Int J Mol Imaging. 2011;2011:405840. doi: 10.1155/2011/405840. Epub 2011 May 4.

7.

Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody.

Robinson MK, Doss M, Shaller C, Narayanan D, Marks JD, Adler LP, González Trotter DE, Adams GP.

Cancer Res. 2005 Feb 15;65(4):1471-8.

8.

Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner.

González Trotter DE, Manjeshwar RM, Doss M, Shaller C, Robinson MK, Tandon R, Adams GP, Adler LP.

J Nucl Med. 2004 Jul;45(7):1237-44.

9.

Modeling the axial extension of a transmission line source within iterative reconstruction via multiple transmission sources.

Bowsher JE, Tornai MP, Peter J, González Trotter DE, Krol A, Gilland DR, Jaszczak RJ.

IEEE Trans Med Imaging. 2002 Mar;21(3):200-15.

PMID:
11989845
10.

Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.

Akabani G, Cokgor I, Coleman RE, González Trotter D, Wong TZ, Friedman HS, Friedman AH, Garcia-Turner A, Herndon JE, DeLong D, McLendon RE, Zhao XG, Pegram CN, Provenzale JM, Bigner DD, Zalutsky MR.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):947-58.

PMID:
10705017

Supplemental Content

Loading ...
Support Center